Skip to content

Fibromyalgia Sleep A to ZZZ Study

At Home Morning Bright Light Treatment for Chronic Nociplastic Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06567886
Enrollment
390
Registered
2024-08-23
Start date
2024-09-27
Completion date
2029-03-01
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Sleep timing stabilization, Morning light therapy

Brief summary

This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.

Detailed description

This study will test a consumer health light therapy device (Re-Timer)

Interventions

DEVICELight Therapy

Participants will self-administer the daily light therapy within a few minutes of their assigned wake up time for one hour. Researchers will provide a light log to note light on/off times, any interruptions to light therapy, and primary activity during light therapy.

BEHAVIORALSleep Stabilization

All participants will be asked to follow a fixed sleep schedule.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute of Nursing Research (NINR)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Meets 2016 revised diagnostic criteria for fibromyalgia (FM) 2. Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits.

Exclusion criteria

1. Significant chronic disease 2. Severe hearing or memory problems 3. Pending medical leave applications at workplace 4. Current pregnancy, breastfeeding, or actively trying to get pregnant 5. Night work or travel outside the eastern time zone within 1 month of the study 6. Other research participation 7. Frequent number of special events during study period (weddings, concerts, exams, etc).

Design outcomes

Primary

MeasureTime frameDescription
Change in Fibromyalgia Impact Questionnaire-Revised (FIQR) scorebaseline (Visit 3, day 8) to post-treatment (Visit 7, approximately day 36).The FIQR is 21 questions. Each question has 11 boxes similar to a visual analog scale. Questions include the difficulty associated with various physical activities and the severity of symptoms. The score for the questions is on a scale from 0 - 100, where lower scores represented better functional status.

Secondary

MeasureTime frameDescription
Change in Brief Pain Inventory (BPI) scorebaseline (Visit 3, day 8) to post-treatment (Visit 7, approximately day 36).The BPI consists of 11 questions and assesses for the presence of pain, pain intensity (i.e., worst, least, average, current) and functional interference from pain. A higher score indicates more pain.

Countries

United States

Contacts

CONTACTHelen Burgess
bhelen@umich.edu734-615-8303
PRINCIPAL_INVESTIGATORAfton Hassett

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026